Insiders · SMTI

Robert Andrew DeSutter

Director at Sanara MedTech Inc. (SMTI)

Robert Andrew DeSutter has filed 6 insider reports with the SEC since February 2022, as director at Sanara MedTech Inc. (SMTI). The latest filing, on June 6, 2026, reports grant or award at Sanara MedTech Inc. (SMTI).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Robert Andrew DeSutter is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Sanara MedTech Inc. logo
SMTI
Sanara MedTech Inc.
Director28,740$32.73Jun 6, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert Andrew DeSutter with

Other insiders at the same companies

Questions about Robert Andrew DeSutter

What is Robert Andrew DeSutter's role at Sanara MedTech Inc.?
Robert Andrew DeSutter reports to the SEC as director at Sanara MedTech Inc. (SMTI), according to the latest filing on June 6, 2026.
How many shares does Robert Andrew DeSutter own?
After the latest filing that states it, Robert Andrew DeSutter directly owned 28,740 shares of Sanara MedTech Inc. (SMTI). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert Andrew DeSutter bought or sold stock recently?
No open-market purchases or sales by Robert Andrew DeSutter are on file. The filings report grant or award.
How do I get alerts when Robert Andrew DeSutter files?
Follow Robert Andrew DeSutter on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert Andrew DeSutter (SEC CIK 0001828759). Totals count each trade once, skipping amendments whose original is on file, from Feb 11, 2022 on. View on SEC EDGAR